chronic atrophic gastritis
Conditions
Interventions
Chronic atrophic gastritis group (tissue fluid sampling in CV12 and non-point areas):none
Sponsors
School of Acupuncture-Moxibustion and Tuina Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1)The patients diagnostic report within 6 months meets the diagnostic criteria for chronic atrophic gastritis and is consistent with OLGA staging system stages III-IV and OLGIM staging system stages 0-V. (2)Between 40 and 65 years of age regardless of gender. (3)Difference between CV12 and non-acupoint pressure pain domains greater than 10N. (4)Patients had good compliance volunteered to participate in the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1)Combined autoimmune gastritis (type A chronic atrophic gastritis) peptic ulcer gastric ulcer duodenal ulcer special type of gastritis or gastrointestinal bleeding; (2)Those whose gastroscopy and pathological biopsy have shown cancer or whose imaging tests suggest cancer metastasis; (3)Those who are taking pain relieving drugs and hormone drugs; (4)Patients with unclear consciousness inability to express subjective symptoms of discomfort and psychiatric patients; (5)Suffering from serious cardiovascular cerebrovascular hepatic renal hematopoietic system diseases malignant tumors and other serious life-threatening diseases; (6)People with scarred body local scarring or injury at the detection points skin diseases and peripheral nervous system diseases; (7)Subjects with diseases that cause abnormal basal body temperature such as metabolic disorders like abnormal thyroid function; (8)Those who have had gastric surgery or have had major surgery resulting in defects or changes in vital organs; (9)Pregnant or lactating women; (10) Those who have undergone acupuncture or participated in other clinical trials within the last six months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differential metabolite concentration;Differential protein concentrations; | — |
Secondary
| Measure | Time frame |
|---|---|
| Metabolomics of tissue fluid;Gastroscopy and pathological biopsy;Gastrointestinal Symptoms Rating Scale;Updated Sydney System;pressure-pain threshold;Proteomics of tissue fluid; | — |
Countries
China
Contacts
Public ContactCunzhi Liu
School of Acupuncture-Moxibustion and Tuina Beijing University of Chinese Medicine
Outcome results
None listed